This is a snippet of the transcript, sign up to read more.
It's more of a 50/50 split. One of the things that always attracted me about Kneat's compensation, which I think is one of the better compensations out there, is the way they tier their opportunities. Up to a certain amount that you sell, there's a standard percentage. If you go higher than that, the percentage increases not only on software but also on services and on the accounts that you grow. The higher you aim to hit a tier, the better the compensation will be for you. That was the incentive for all of us. When you wanted to hit a number, that's what you aimed for. You were trying to reach that point where you thought, "Gosh, this looks really great. If I can get to X number, sell X amount of volume, it's going to get me X amount of commission." So you're always aiming to reach that next tier in the compensation structure.
This is a snippet of the transcript, sign up to read more.
When ValGenesis comes into play and the budget is in IT, they typically have a better chance, I would say an 80% chance of winning it because they are trying to capture that market space, so their software is very low cost. It really does matter.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research